Skip to main content
Close up of a hand using a tablet

Latest News

2024 Gideon A. Rodan Excellence in Mentorship Award

Angela Cheung, M.D., Ph.D. is the recipient of the 2024 Gideon A. Rodan Excellence in Mentorship Award which is given annually in recognition of outstanding support provided by a senior scientist who has helped promote the independent careers of young investigators in bone and mineral metabolism.

The ASBMR Esteemed Awards are the Society’s most prestigious awards given to members who have made significant contributions and who promote excellence in bone and mineral research.

Angela Cheung, M.D., Ph.D.  2024 Gideon A. Rodan Excellence in Mentorship Award Recipient

Dr. Angela M. Cheung is Professor of Medicine at University of Toronto, Senior Physician Scientist at University Health Network, and holds a Tier 1 Canada Research Chair in Postmenopausal and Musculoskeletal Health. She obtained her M.D. from Johns Hopkins University in 1988 and her Ph.D. in Health Policy from Harvard University in 1997. She is a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for more than 30 years. Dr. Cheung is also a member of Osteoporosis Canada’s Scientific Advisory Council, a member of the IOF Council of Scientific Advisors and the President-Elect of ISCD.

This award will be presented during the ASBMR 2024 Annual Meeting in Toronto this September.

Congratulations to Dr. Angela Cheung!


OC MAKES THE NEWS – RECENT ITEMS

Researchers Use Machine Learning To Better Predict Fractures Caused By Weak Bones

July 7, 2026

Latest News Researchers Use Machine Learning To Better Predict Fractures Caused By Weak Bones July 7, 2026 Fragility fractures are a major and growing health burden, with significant personal and […]

INESSS in Quebec has issued a recommendation to transfer denosumab from the Exceptional Drugs section to the Regular section

June 23, 2026

Latest News INESSS in Quebec has issued a recommendation to transfer denosumab from the Exceptional Drugs section to the Regular section June 23, 2026 INESSS (the Institut national d’excellence en […]

Health Canada Approves of DENOZA™, a Denosumab Biosimilar

May 5, 2026

Latest News Health Canada Approves of DENOZA™, a Denosumab Biosimilar May 5, 2026 Apotex Inc., a Canadian based global pharmaceutical company announced that Health Canada has approved DENOZA™ (denosumab injection), […]

© Osteoporosis Canada, 2026
Charitable Registration No. 89551 0931 RR 0001